Functional excipients to drive US market to $2bn by 2015, study Functional excipients to drive US market to $2bn by 2015, study 08-Jun-2011 Demand for functional excipients will drive growth of the US market over the next few years according to new analysis.
Excipact auditing certification scheme explained 08-Jun-2011 By Gareth Macdonald April saw the publication of the second draft of Excipact, a set of certification standards for third-party auditors of excipient manufacturers.
Lonza announces CHF10m Singapore biomanufacturing expansion Lonza announces CHF10m Singapore biomanufacturing expansion 08-Jun-2011 By Gareth Macdonald Switzerland-based life sciences supplier Lonza says it will invest CHF10m (€8m) to expand a Singapore plant that is part of its custom biomanufacturing business.
SAFC and Pfenex partner on protein production SAFC and Pfenex partner on protein production 08-Jun-2011 By Gareth Macdonald US supplier SAFC has teamed up with Pfenex in a partnership focused on the production of therapeutic proteins and vaccine components.
Cangene wins $61m extension to BARDA supply deal Cangene wins $61m extension to BARDA supply deal 08-Jun-2011 By Nick Taylor BARDA is extending its botulism antitoxin supply contract with Cangene, adding $61m (€42m) to the value of the deal over the next three to four years.
People on the move, pharma outsourcing jobs People on the move, pharma outsourcing jobs 08-Jun-2011 By Gareth Macdonald Outsourcing-Pharma presents a round up of the latest appointments in the pharmacuetical outsourcing sector.
Parexel to close four sites in early stage cuts Parexel to close four sites in early stage cuts 08-Jun-2011 By Nick Taylor Parexel is closing four facilities and downsizing another five in a restructuring of its loss making early phase unit.
